Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 13, Issue 4, 2007, Pages 211-212

  Zhang, Xuan ^a   Tian, Xinping ^a   Zhang, Fengchun ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Central nervous system; Premature atherosclerosis; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; LUPUS ANTICOAGULANT; PREDNISOLONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BABINSKI REFLEX; BLOOD PRESSURE; BRAIN INFARCTION; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONSCIOUSNESS DISORDER; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEROLOGY; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CEREBRAL INFARCTION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; PLATELET AGGREGATION INHIBITORS; PREMENOPAUSE; RISK FACTORS; UNCONSCIOUSNESS;

EID: 34548429648     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318133476d     Document Type: Article

References (12)

1. Mattu A, Petrini J, Swencki S, et al. Premature atherosclerosis and acute coronary syndrome in systemic lupus erythematosus. Am J Emerg Med. 2005;23:696-703.
2. Nikpour M, Urowitz MB, Gladman DD. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am. 2005;31:329-354, vii-viii.
3. Rhew EY, Ramsey-Goldman R. Premature atherosclerotic disease in systemic lupus erythematosus - role of inflammatory mechanisms. Autoimmun Rev. 2006;5:101-105.
4. Zampieri S, Iaccarino L, Ghirardello A, et al. Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Ann N Y Acad Sci. 2005;1051:351-361.
5. Dong Y, Zhang X, Tang F, et al. Intrathecal injection with methotrexate plus dexamethasone in the treatment of central nervous system involvement in systemic lupus erythematosus. Chin Med J (Engl). 2001;114:764-766.
6. Zhang X, Dong Y, Tang F, et al. [Central nervous system involvement in systemic lupus erythematosus]. Zhonghua Nei Ke Za Zhi. 1999;38:681-684.
7. Zhang X, Shu H, Zhang F, et al. Cell-ELISA detection of anti-neuronal antibodies in central nervous system involvement of SLE. Ann Rheum Dis. 2007;66:530-532.
8. Zhang X, Zhu Z, Zhang F, et al. Diagnostic value of single-photone- mission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: a case-control study. Arthritis Rheum. 2005;53:845-849.
9. Abou-Raya A, Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev. 2006;5:331-337.
10. Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2003;62:1071-1077.
11. Ettinger WH, Goldberg AP, Applebaum-Bowden D, Hazzard WR. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. Am J Med. 1987;83:503-508.
12. Major AS, Singh RR, Joyce S, Van Kaer L. The role of invariant natural killer T cells in lupus and atherogenesis. Immunol Res. 2006;34:49-66.